• 1. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
• 2. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 3. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 4. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 5. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378

Recent Advances in the Application of 5-Bromo-2-cyclopropoxypyridine (CAS: 1243318-10-6) in Chemical Biology and Pharmaceutical Research

5-Bromo-2-cyclopropoxypyridine (CAS: 1243318-10-6) is a heterocyclic compound that has garnered significant attention in recent years due to its versatile applications in medicinal chemistry and drug discovery. This compound serves as a key intermediate in the synthesis of various biologically active molecules, particularly in the development of kinase inhibitors and other small-molecule therapeutics. Recent studies have highlighted its potential in targeting specific enzymatic pathways involved in cancer, inflammation, and infectious diseases.

One of the most notable applications of 5-Bromo-2-cyclopropoxypyridine is its role in the synthesis of Bruton's tyrosine kinase (BTK) inhibitors. BTK is a critical enzyme in B-cell receptor signaling, and its inhibition has shown promise in treating B-cell malignancies and autoimmune disorders. Researchers have utilized 5-Bromo-2-cyclopropoxypyridine as a building block to develop novel BTK inhibitors with improved selectivity and pharmacokinetic properties. Recent preclinical studies have demonstrated the efficacy of these inhibitors in reducing tumor growth and inflammation in animal models.

In addition to its role in BTK inhibition, 5-Bromo-2-cyclopropoxypyridine has been employed in the design of antiviral agents. A 2023 study published in the Journal of Medicinal Chemistry reported the synthesis of a series of pyridine-based compounds, including derivatives of 5-Bromo-2-cyclopropoxypyridine, that exhibited potent activity against RNA viruses such as SARS-CoV-2 and influenza. These findings underscore the compound's potential as a scaffold for developing broad-spectrum antiviral therapeutics.

The chemical versatility of 5-Bromo-2-cyclopropoxypyridine also extends to its use in proteolysis-targeting chimeras (PROTACs). PROTACs are a novel class of therapeutics that degrade target proteins via the ubiquitin-proteasome system. Recent research has demonstrated that 5-Bromo-2-cyclopropoxypyridine can be incorporated into PROTACs to selectively degrade disease-relevant proteins, offering a promising strategy for tackling drug-resistant cancers and other challenging conditions.

Despite its promising applications, challenges remain in optimizing the synthetic routes and scalability of 5-Bromo-2-cyclopropoxypyridine. A 2022 study in Organic Process Research & Development highlighted the need for more efficient and environmentally friendly synthesis methods to meet the growing demand for this compound in pharmaceutical development. Future research directions may focus on green chemistry approaches and catalytic processes to enhance the sustainability of its production.

In conclusion, 5-Bromo-2-cyclopropoxypyridine (CAS: 1243318-10-6) represents a valuable tool in modern drug discovery, with applications spanning kinase inhibition, antiviral therapy, and targeted protein degradation. Continued research into its chemical properties and biological activities will likely yield further innovations in the treatment of complex diseases. The compound's versatility and efficacy make it a focal point for ongoing and future studies in the chemical biology and pharmaceutical fields.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)